Detalhe da pesquisa
1.
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease.
Clin Exp Pharmacol Physiol
; 40(5): 333-7, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23528035
2.
An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy.
Pituitary
; 11(1): 1-11, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17690987
3.
High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study.
J Clin Endocrinol Metab
; 102(7): 2454-2464, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419317
4.
Acromegaly is associated with increased cancer risk: a survey in Italy.
Endocr Relat Cancer
; 24(9): 495-504, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28710115
5.
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage.
J Clin Endocrinol Metab
; 91(4): 1397-403, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16449332
6.
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?
J Clin Endocrinol Metab
; 88(7): 3090-8, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12843148
7.
Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.
J Clin Endocrinol Metab
; 97(10): 3467-75, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22767639
8.
Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy.
Eur J Endocrinol
; 164(3): 341-7, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21212103
9.
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.
Eur J Endocrinol
; 161(2): 331-8, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19465485
10.
Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter study.
Endocr Pract
; 14(7): 846-55, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18996812